FireCyte Therapeutics, Inc. — Form D
FireCyte Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-01. The offering totals $12.0M, of which $5.5M was reported sold. Industry: Other.
Offering
- Filed: 2022-02-01
- Form: D
- Accession: 0001908231-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $5.5M
- Remaining: $6.5M
- Investors: 3
- Date of first sale: 2022-01-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-431729
Issuer
- Name: FireCyte Therapeutics, Inc.
- CIK: 0001908231
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 215 FIRST STREET, SUITE 500, CAMBRIDGE, MA, 02142
- Phone: 5083442319
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Meredith E Fisher | Director | Cambridge, MA |
| Ruoxi E Hu | Director | Cambridge, MA |
| Charles E Kunsch | Director | Cambridge, MA |
| William E Yelle | Director | Cambridge, MA |
| William E Yelle | Executive Officer | Cambridge, MA |
More